As we age, our bodies become less efficient at recycling NAD, which is crucial for cellular function. Certain proteins, like CD38, can hinder this process by breaking down NAD more rapidly. Intravenous methods may provide a solution, delivering NAD directly and effectively overwhelming these regulatory systems.
